<DOC>
	<DOCNO>NCT01947153</DOCNO>
	<brief_summary>The objective current study demonstrate bioequivalence two 2.5 mg linagliptin/500 mg metformin fix dose combination tablet compare free combination linagliptin 5 mg metformin 1000 mg healthy male female volunteer .</brief_summary>
	<brief_title>Two-way Crossover Study Healthy Male Female Subjects Evaluate Bioequivalence JentaduetoÂ® .</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation Healthy male females accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG clinical laboratory test ( haematology , clinical chemistry urinalysis ) . Age 18 45 year ( incl . ) Body mass index Quetelet 18.50 24.99 kg/m2 ( incl . ) Female subject childbearing potential agree use doublebarrier contraception study . If female postmenopausal ( menses least 2 year ) surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) exempt requirement . In case use oral contraceptive , withdraw least 2 month first drug dosing . Male subject agree use effective contraception study ( barrier contraceptive method ) Exclusion criterion : Any find medical examination ( include BP , PR ECG ) deviate normal clinical relevance Any laboratory value outside reference range clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Positive result blood test infection ( HIV , syphilis , hepatitis B C ) A positive urine drug screen test screen admission trial site treatment period . A positive alcohol breath test screen admission trial site treatment period . Surgery gastrointestinal tract ( except appendectomy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>